Labiotech.eu

News and Trends 24 Aug 2015

Monoclonal Antibodies celebrate their 40th birthday, how were they discovered and changed the world?

It’s been 40 years now since the first monoclonal antibodies have been manufactured by researchers from UK’s Medical Research Council (MRC). Let’s go back to the beginning and see how they became global blockbusters. One cannot imagine today’s medical portfolio without monoclonal antibodies. Checkpoint therapies against cancer, immunosuppressives treating multiple sclerosis, vaccines against everything … […]

August 24, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 24 Aug 2015

Novartis signs $1Bn deal for GSK’s Multiple Sclerosis Antibody

Is this Novartis‘ next blockbuster? The Swiss company has acquired GlaxoSmithKline‘s (GSK) immunosuppressive antibody Ofatumumab for up to $1Bn. The new drug allows Novartis to enter the multiple sclerosis market for the third time. Earlier this year, Novartis purchased GSK’s oncology portfolio for $16 billion (€14Bn), including the fully human monoclonal anitbody Ofatumumab, which is […]

August 24, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 22 Aug 2015

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Welcome in our Top of the week list! This week is full of uncommon stories. Did you know that we can create the best coffee from Biotech techniques? The New York-based startup Afineur can do this! Even more crazy, what do you think of a DNA-made computer? Quite strange, right! Well, if you’re curious, read […]

August 22, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 21 Aug 2015

Researchers dismantle one of Bacteria’s most wicked weapons: The Molecular Crossbow

Researchers from the Institut Pasteur and the National Center for Scientific Research in Paris have elucidated the molecular structure of a crossbow-like weapon from bacteria’s arsenal. Ultimately, this could help to fight infectious diseases. Bacteria are in a constant battle with innumerable other microbes in their environment, so they have to bring in the big guns to […]

August 21, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 21 Aug 2015

50 000 visitors came between January 1st and today, that’s crazy !!

Hi there, I must say I was also surprised seeing this crazy number, but it’s true. 50 000 visitors have been visiting Labiotech.eu since January 1st. That’s so amazing! A big energy boost to finish the summer in the office and to start September at 200%. Congrats to the 15 people who worked hard with us […]

August 21, 2015 - 1 minutemin - By Philip Hemme

News and Trends 20 Aug 2015

Lundbeck dismisses 1,000 employees to stay competitive

Lundbeck’s new CEO Kåre Schultz completely restructures the company to regain profitability. About 1/6th of the company’s employees will have to leave for that reason. In May, former president and COO of Novo Nordisk Kåre Schultz became the new president and CEO of Lundbeck. The Danish drugmaker was struggling at that time because the patent of its blockbuster […]

August 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 20 Aug 2015

DNA to play an essential role in the future of Computers?

You can do terrific things with DNA – convicting a murderer, confirming the right father … and building computers! As biomolecular computing is ever-growing, scientists from the University of East Anglia found a new way to convert DNA in a switching mechanism. This could be used in new bio-computers built from DNA. The structure of […]

August 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Sobi gets a long-lasting grip on a rare type of Hemophilia

In the 19th century, Queen Victoria passed the Hemophilia B to diverse royal houses of Europe. Today, its characteristic heavy bleedings can be treated quite well, as Swedish Orphan Biovitrum (Sobi) and its partner Biogen showed in the results of an ongoing long-term study. Sobi was formed in 2001 through a fusion of several units […]

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Paris is Europe’s biggest Biocluster, but nobody knows it …

Paris is well-known for being the most beautiful city in the world. But did you also know that it concentrates most of the French Biotech industry and is Europe’s biggest biocluster? If not, why didn’t you know? The Eiffel Tower, the Louvre, Notre Dame and so many other monuments makes Paris outstanding and unique. But Paris […]

August 19, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Top 5 Biotech Books to Enjoy your Summer on the Beach

Summer is a great time to read books and get inspired for the year to come. Here’s a Top 5 list of my recommendations to read before summer ends. 1. Genentech: The Beginnings of Biotech Genentech is considered the founder of the Biotech industry in the late 80s. It started from breakthrough science, crazy scientists and very risk-taking […]

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

New mAb-treatment Improves the Life of European Children with Neuroblastoma

The European Commission granted marketing authorisation for United Therapeutics‘ Unituxin for the treatment of neuroblastoma in patients aged 12 months to 17 years. In Europe, approximately 1500 patients are diagnosed with neuroblastoma, the most common cancer in children. Some patients – the low-risk and intermediate risk group – are favored by an excellent prognosis with cure rates […]

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

Not only Genes matter, Cellular Origin determines the Cancer Type

Cancer occurs in uncountable forms, and we are far away from understanding all the mechanisms that lead to its variety. For example, did you know that not only the mutated gene is responsible for the emerging of a certain type of cancer but also its cellular origin? That’s what researcher from Belgium and Australia just […]

August 18, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Monoclonal Antibodies celebrate their 40th birthday, how were they discovered and changed the world?

Novartis signs $1Bn deal for GSK’s Multiple Sclerosis Antibody

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Researchers dismantle one of Bacteria’s most wicked weapons: The Molecular Crossbow

50 000 visitors came between January 1st and today, that’s crazy !!

Lundbeck dismisses 1,000 employees to stay competitive

DNA to play an essential role in the future of Computers?

Sobi gets a long-lasting grip on a rare type of Hemophilia

Paris is Europe’s biggest Biocluster, but nobody knows it …

Top 5 Biotech Books to Enjoy your Summer on the Beach

New mAb-treatment Improves the Life of European Children with Neuroblastoma

Not only Genes matter, Cellular Origin determines the Cancer Type

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!